520 related articles for article (PubMed ID: 6210364)
1. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
Ordeig J; Guardia J
J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
[TBL] [Abstract][Full Text] [Related]
2. Significance of antikeratin antibodies in rheumatoid arthritis.
Hajiroussou VJ; Skingle J; Gillett AP; Webley M
J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092
[TBL] [Abstract][Full Text] [Related]
3. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.
Vasiliauskiene L; Wiik A; Høier-Madsen M
Ann Rheum Dis; 2001 May; 60(5):459-66. PubMed ID: 11302867
[TBL] [Abstract][Full Text] [Related]
5. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
[TBL] [Abstract][Full Text] [Related]
6. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
7. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
[No Abstract] [Full Text] [Related]
8. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor.
Cordonnier C; Meyer O; Palazzo E; de Bandt M; Elias A; Nicaise P; Haïm T; Kahn MF; Chatellier G
Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
10. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'.
Vincent C; Serre G; Lapeyre F; Fournié B; Ayrolles C; Fournié A; Soleilhavoup JP
Ann Rheum Dis; 1989 Sep; 48(9):712-22. PubMed ID: 2478084
[TBL] [Abstract][Full Text] [Related]
11. Antikeratin antibodies in rheumatoid arthritis. Methods and clinical significance.
Kirstein H; Mathiesen FK
Scand J Rheumatol; 1987; 16(5):331-8. PubMed ID: 2446384
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection.
Cojocaru M; Cojocaru IM; Iacob SA
Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142
[TBL] [Abstract][Full Text] [Related]
13. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.
Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E
J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797
[TBL] [Abstract][Full Text] [Related]
14. [Antikeratin antibodies in rheumatoid arthritis].
Larsen HL
Ugeskr Laeger; 1991 May; 153(22):1567-71. PubMed ID: 1711726
[TBL] [Abstract][Full Text] [Related]
15. [Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects].
Serre G; Vincent C; Fournié B; Lapeyre F; Soleilhavoup JP; Fournié A
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):607-14. PubMed ID: 2441454
[TBL] [Abstract][Full Text] [Related]
16. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study.
Boki KA; Kurki P; Holthofer H; Tzioufas AG; Drosos AA; Moutsopoulos HM
J Rheumatol; 1995 Nov; 22(11):2046-8. PubMed ID: 8596142
[TBL] [Abstract][Full Text] [Related]
18. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
19. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
